Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-012399
Filing Date
2022-10-18
Accepted
2022-10-18 12:45:57
Documents
1
Period of Report
2022-10-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57323.html 4  
1 PRIMARY DOCUMENT marketforms-57323.xml 4 5425
  Complete submission text file 0001214659-22-012399.txt   6985
Mailing Address 230 GOLDEN BEACH DRIVE GOLDEN BEACH FL 33160
Business Address
Goldfarb Robert I (Reporting) CIK: 0001337910 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55320 | Film No.: 221315502

Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Issuer) CIK: 0001625288 (see all company filings)

EIN.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations